Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 2c
February 15, 2022 4:10 PM ESTAdaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.43), $0.02 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $36.7 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
... More